Delisting riskPopularity #4,483
Scienture (SCNX)
Specialty drug developer commercializing differentiated formulations for cardiovascular and CNS care.
$0.2815
vs last close−0.00 (−1.26%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
estimated · in 50 days
EPS estimate
−$0.06
Revenue estimate
$1.6M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.82−$0.33−$0.48−$0.19−$1.76−$0.08−$0.07Pending
Estimate————−$0.22−$0.23−$0.09−$0.06
Surprise————−700.0%+65.2%+22.2%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$53.1K$10.3K—$590.1K−$168.7K$56.3K$343.6KPending
Estimate$2.5M———$486.4K$401.0K$2.0M$1.6M
Surprise−97.9%———−134.7%−86.0%−82.5%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2026 | −$0.03 | — | — |
| Nov 2026 | −$0.06 | — | — |
| Aug 2026 | −$0.09 | −$0.07 | +22.2% |
| May 2026 | −$0.23 | −$0.08 | +65.2% |
| Mar 2026 | −$0.22 | −$1.76 | −700.0% |
| Nov 2025 | — | −$0.19 | — |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Jun 2024 | |||
| Apr 2024 | |||
| Jan 2024 | |||
| Aug 2023 | |||
| Jun 2023 | |||
| May 2023 | |||
| Dec 2022 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Sep 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Sep 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2026 | −$0.03 | — | — | $2.8M | — | — | — |
| Nov 12, 2026 | −$0.06 | — | — | $1.6M | — | — | — |
| Aug 13, 2026 | −$0.09 | −$0.07 | +22.2% | $2.0M | $343.6K | −82.5% | +3.3% |
| May 11, 2026 | −$0.23 | −$0.08 | +65.2% | $401.0K | $56.3K | −86.0% | −1.5% |
| Mar 24, 2026 | −$0.22 | −$1.76 | −700.0% | $486.4K | −$168.7K | −134.7% | −5.1% |
| Nov 12, 2025 | — | −$0.19 | — | — | $590.1K | — | −4.0% |
| Aug 12, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 26, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 9, 2024 | |||||||
| Jun 26, 2024 | |||||||
| Apr 22, 2024 | |||||||
| Jan 16, 2024 | |||||||
| Aug 18, 2023 | |||||||
| Jun 30, 2023 | |||||||
| May 15, 2023 | |||||||
| Dec 31, 2022 | |||||||
| Sep 30, 2022 | |||||||
| Jun 30, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Dec 31, 2021 | |||||||
| Sep 30, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Sep 30, 2015 |